Market Value210,862,000
Total Holdings45
File Date2022-05-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
CERS / Cerus Corporation
LIFE / aTyr Pharma, Inc.
EXAS / Exact Sciences Corporation
BEAM / Beam Therapeutics Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
TSVT / 2seventy bio, Inc.
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
NFH / New Frontier Health Corporation - Class A
NFH.WS / New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
SRZN / Surrozen, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
DICE / DICE Therapeutics Inc
TCRX / TScan Therapeutics, Inc.
KURA / Kura Oncology, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
MRTX / Mirati Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
PRLD / Prelude Therapeutics Incorporated
SRPT / Sarepta Therapeutics, Inc.
RANI / Rani Therapeutics Holdings, Inc.
DYNE / Dyntek Inc
SRRA / Sierra Oncology Inc
TCRR / Tcr2 Therapeutics Inc
SYBX / Synlogic, Inc.
SLGC / Standard BioTools Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
VINC / Vincerx Pharma, Inc.
CCXI / ChemoCentryx Inc
ALXO / ALX Oncology Holdings Inc.
VIR / Vir Biotechnology, Inc.
RUBY / Rubius Therapeutics, Inc.
STSA / Satsuma Pharmaceuticals Inc
BCRX / BioCryst Pharmaceuticals, Inc.
KRTX / Karuna Therapeutics, Inc.
BLUE / bluebird bio, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
TVTX / Travere Therapeutics, Inc.
EAR / Eargo, Inc.
OTIC / Otonomy Inc
NVTA / Invitae Corporation
RETA / Reata Pharmaceuticals Inc - Class A
BOLT / Bolt Biotherapeutics, Inc.
AFMD / Affimed N.V.
SGEN / Seagen Inc
REPL / Replimune Group, Inc.
KYMR / Kymera Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ACAD / ACADIA Pharmaceuticals Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
PACB / Pacific Biosciences of California, Inc.
INCY / Incyte Corporation
FGEN / FibroGen, Inc.
GRTX / Galera Therapeutics, Inc.
ILMN / Illumina, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
TRDA / Entrada Therapeutics, Inc.
ABCL / AbCellera Biologics Inc.
KOD / Kodiak Sciences Inc.
BMRN / BioMarin Pharmaceutical Inc.
EXAI / Exscientia plc - Depositary Receipt (Common Stock)
EXEL / Exelixis, Inc.
KALV / KalVista Pharmaceuticals, Inc.